• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

企业如何为医疗材料定价:一项多国研究。

How firms set prices for medical materials: a multi-country study.

机构信息

Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA.

出版信息

Health Policy. 2009 Sep;92(1):73-8. doi: 10.1016/j.healthpol.2009.03.003. Epub 2009 Apr 1.

DOI:10.1016/j.healthpol.2009.03.003
PMID:19342115
Abstract

OBJECTIVES

This study presents a comparison of medical material prices, discusses why differences exist, and examines methods for comparing prices.

METHODS

Market prices for drug-eluting stents (DES), non-drug-eluting stents (non-DES), and percutaneous transluminal coronary angioplasty (PTCA) catheters were collected from five countries: the United States, Japan, Korea, Turkey, and Thailand. To compare prices, three adjustment methods were used: currency exchange rates, purchasing power parity (PPP), and gross domestic product (GDP) per capita.

RESULTS

The ratios of medical material prices compared with those in the United States were higher in Japan (from 1.4 for DES to 5.0 for PTCA catheters) and Korea (from 1.2 for DES to 4.0 for PTCA catheters), and lower in Turkey (from 0.8 for non-DES to 1.4 for DES) and Thailand (from 0.5 for non-DES to 1.3 for PTCA catheters). The PPP-adjusted ratios changed slightly for Japan, Korea, and Turkey. When the prices were adjusted by GDP per capita, the ratios were much higher.

CONCLUSIONS

Comparing prices using currency exchange rates or PPP is applicable only between countries with stable economic relations; adjustment by GDP per capita reflects the actual burden. Further study is needed to fully elucidate the factors influencing the global medical material market.

摘要

目的

本研究比较了医疗材料价格,探讨了价格存在差异的原因,并考察了比较价格的方法。

方法

从美国、日本、韩国、土耳其和泰国五个国家收集药物洗脱支架(DES)、非药物洗脱支架(non-DES)和经皮冠状动脉成形术(PTCA)导管的市场价格。为了比较价格,使用了三种调整方法:货币汇率、购买力平价(PPP)和人均国内生产总值(GDP)。

结果

与美国相比,日本(DES 为 1.4 倍,PTCA 导管为 5.0 倍)和韩国(DES 为 1.2 倍,PTCA 导管为 4.0 倍)的医疗材料价格比率较高,土耳其(non-DES 为 0.8 倍,DES 为 1.4 倍)和泰国(non-DES 为 0.5 倍,PTCA 导管为 1.3 倍)的价格比率较低。日本、韩国和土耳其的 PPP 调整后的比率略有变化。当按人均 GDP 调整价格时,比率要高得多。

结论

仅在经济关系稳定的国家之间使用货币汇率或 PPP 进行价格比较是可行的;按人均 GDP 调整反映了实际负担。需要进一步研究以充分阐明影响全球医疗材料市场的因素。

相似文献

1
How firms set prices for medical materials: a multi-country study.企业如何为医疗材料定价:一项多国研究。
Health Policy. 2009 Sep;92(1):73-8. doi: 10.1016/j.healthpol.2009.03.003. Epub 2009 Apr 1.
2
[Cost analysis of percutaneous coronary intervention and coronary artery bypass grafting in Japan and USA].
Nihon Rinsho. 2003 Apr;61 Suppl 4:632-7.
3
The euros and sense of stents: do we get value for money?支架的成本效益:我们物有所值吗?
J Cardiovasc Med (Hagerstown). 2011 Dec;12(12):878-82. doi: 10.2459/JCM.0b013e32834da507.
4
Price disparity of percutaneous coronary intervention devices in Japan and the United States in 2006.2006年日本和美国经皮冠状动脉介入治疗器械的价格差异
Circ J. 2007 Jul;71(7):1128-30. doi: 10.1253/circj.71.1128.
5
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.西罗莫司洗脱支架治疗复杂冠状动脉狭窄的成本效益:来自西罗莫司洗脱球囊扩张支架治疗初发原发性冠状动脉病变患者(SIRIUS)试验的结果。
Circulation. 2004 Aug 3;110(5):508-14. doi: 10.1161/01.CIR.0000136821.99814.43. Epub 2004 Jul 19.
6
Selection of patients for drug-eluting stents based on insurance coverage: pay or don't play.
JACC Cardiovasc Interv. 2010 Jul;3(7):780-2. doi: 10.1016/j.jcin.2010.05.006.
7
Current disparities in the prices of medical materials between Japan and the United States: further investigation of cardiovascular medical devices.日本与美国之间医疗材料价格的当前差异:心血管医疗设备的进一步调查
J Cardiol. 2007 Feb;49(2):77-81.
8
Assessing the impact of drug-eluting stents. Hospitals must be prepared to absorb a potentially negative financial impact.评估药物洗脱支架的影响。医院必须做好准备,以承受潜在的负面财务影响。
Healthc Exec. 2003 Jul-Aug;18(4):60-1.
9
Impact of change in the price of percutaneous coronary intervention devices on medical expenses.经皮冠状动脉介入治疗器械价格变化对医疗费用的影响。
Circ J. 2003 Jul;67(7):576-8. doi: 10.1253/circj.67.576.
10
Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario.在安大略省进行的一项大型前瞻性研究中,对药物洗脱支架与裸金属支架进行经济评估。
Int J Technol Assess Health Care. 2009 Apr;25(2):196-207. doi: 10.1017/S0266462309090254. Epub 2009 Mar 31.